Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Tag Archives: gefitinib
Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations
Gefitinib (Iressa) is more effective than first-line therapy in improving survival without disease in patients with advanced nonsmall-cell lung cancer (NSCLC) and epidermal growth-factor receptor (EGFR) mutations. The current study was conducted in 230 patients from 43 centers in Japan, … Continue reading
Posted in Lung Cancer, Non Small Cell Lung Cancer
Tagged carboplatin, EGFR, epidermal growth-factor receptor, gefitinib, Iressa, Lung Cancer, mutations, Non small cell lung cancer, paclitaxel, Survival
Comments Off on Gefitinib (Iressa) is better than Standard Therapy in Lung Cancer with EGFR Mutations
Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
According to a new study published in the Clinical Cancer Research, adding epidermal growth factor receptor (EGFR) inhibitor gefitinib (Iressa) to anastrozole (Arimidex) improved progression-free survival in postmenopausal women with hormone receptor-positive metastatic breast cancer. The study randomized 93 postmenopausal … Continue reading
Posted in Breast cancer, Cancer
Tagged anastrozole, Arimidex, Breast cancer, gefitinib, Iressa, Survival
Comments Off on Gefitinib Improves Progression-Free Survival in Metastatic Breast Cancer
